CSIMarket
 
Spyglass Pharma Inc   (NASDAQ: SGP)
    Sector • Consumer Non Cyclical    Industry • Diversified
   Industry • Diversified
   Sector • Consumer Non Cyclical
 

Spyglass Pharma Inc's Suppliers Performance

SGP's Supply Chain




 
SGP Costs vs Sales of Suppliers Growth

• More on SGP Suppliers






Spyglass Pharma Inc's Comment on Supply Chain


The company sources its intraocular lenses (IOLs) from an ISO13485-certified and FDA-registered contract manufacturing organization (CMO) under a supply agreement with a two-year termination notice. This agreement currently excludes rights for clinical trials or commercialization in the People's Republic of China but may be expanded if the CMO acquires such rights. An affiliate of the CMO holds a right of first negotiation to become an exclusive distributor in Asia, Europe, the Middle East, and Africa. The BIM-IOL System is compatible with various off-the-shelf injectors, and the company has a supply agreement with an injector manufacturer for global distribution. The company may pursue additional agreements with other injector manufacturers.

Spyglass Pharma Inc's Comment on Supply Chain


The company sources its intraocular lenses (IOLs) from an ISO13485-certified and FDA-registered contract manufacturing organization (CMO) under a supply agreement with a two-year termination notice. This agreement currently excludes rights for clinical trials or commercialization in the People's Republic of China but may be expanded if the CMO acquires such rights. An affiliate of the CMO holds a right of first negotiation to become an exclusive distributor in Asia, Europe, the Middle East, and Africa. The BIM-IOL System is compatible with various off-the-shelf injectors, and the company has a supply agreement with an injector manufacturer for global distribution. The company may pursue additional agreements with other injector manufacturers.







SGP's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Spyglass Pharma Inc 45,125.69 17,887.00 2,471.00 -
SUBTOTAL 0.00 0.00 0.00 -


Sources: Spyglass Pharma Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Spyglass Pharma Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.